| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 1,694 | 469 |
| Net decrease in cash, cash equivalents and restricted cash | -56,668 | -40,561 |
| Cash and cash equivalents at beginning of period | 293,913 | - |
| Cash and cash equivalents at end of period | 237,245 | - |
Arcturus Therapeutics Holdings Inc. (ARCT)
Arcturus Therapeutics Holdings Inc. (ARCT)